Stress-induced responses of human skin fibroblasts in vitro reflect human longevity

Unlike various model organisms, cellular responses to stress have not been related to human longevity. We investigated cellular responses to stress in skin fibroblasts that were isolated from young and very old subjects, and from offspring of nonagenarian siblings and their partners, representatives of the general population. Fibroblasts were exposed to rotenone and hyperglycemia and assessed for senescence‐associated β‐galactosidase (SA‐β‐gal) activity by flow cytometry. Apoptosis/cell death was measured with the Annexin‐V/PI assay and cell‐cycle analysis (Sub‐G1 content) and growth potential was determined by the colony formation assay. Compared with fibroblasts from young subjects, baseline SA‐β‐gal activity was higher in fibroblasts from old subjects (P = 0.004) as were stress‐induced increases (rotenone: P < 0.001, hyperglycemia: P = 0.027). For measures of apoptosis/cell death, fibroblasts from old subjects showed higher baseline levels (Annexin V+/PI+ cells: P = 0.040, Sub‐G1: P = 0.014) and lower stress‐induced increases (Sub‐G1: P = 0.018) than fibroblasts from young subjects. Numbers and total size of colonies under nonstressed conditions were higher for fibroblasts from young subjects (P = 0.017 and 0.006, respectively). Baseline levels of SA‐β‐gal activity and apoptosis/cell death were not different between fibroblasts from offspring and partner. Stress‐induced increases were lower for SA‐β‐gal activity (rotenone: P = 0.064, hyperglycemia: P < 0.001) and higher for apoptosis/cell death (Annexin V+/PI? cells: P = 0.041, Annexin V+/PI+ cells: P = 0.008). Numbers and total size of colonies under nonstressed conditions were higher for fibroblasts from offspring (P = 0.001 and 0.024, respectively) whereas rotenone‐induced decreases were lower (P = 0.008 and 0.004, respectively). These data provide strong support for the hypothesis that in vitro cellular responses to stress reflect the propensity for human longevity.     

Determinants of Hepatitis C Virus p7 Ion Channel Function and Drug Sensitivity Identified In Vitro

Hepatitis C virus (HCV) chronically infects 170 million individuals, causing severe liver disease. Although antiviral chemotherapy exists, the current regimen is ineffective in 50% of cases due to high levels of innate virus resistance. New, virus-specific therapies are forthcoming although their development has been slow and they are few in number, driving the search for new drug targets. The HCV p7 protein forms an ion channel in vitro and is critical for the secretion of infectious virus. p7 displays sensitivity to several classes of compounds, making it an attractive drug target. We recently demonstrated that p7 compound sensitivity varies according to viral genotype, yet little is known of the residues within p7 responsible for channel activity or drug interactions. Here, we have employed a liposome-based assay for p7 channel function to investigate the genetic basis for compound sensitivity. We demonstrate using chimeric p7 proteins that neither the two trans-membrane helices nor the p7 basic loop individually determines compound sensitivity. Using point mutation analysis, we identify amino acids important for channel function and demonstrate that null mutants exert a dominant negative effect over wild-type protein. We show that, of the three hydrophilic regions within the amino-terminal trans-membrane helix, only the conserved histidine at position 17 is important for genotype 1b p7 channel activity. Mutations predicted to play a structural role affect both channel function and oligomerization kinetics. Lastly, we identify a region at the p7 carboxy terminus which may act as a specific sensitivity determinant for the drug amantadine.Hepatitis C virus (HCV) chronically infects 170 million individuals and is a major cause of severe liver disease such as cirrhosis and hepatocellular carcinoma. Acute HCV infection is asymptomatic which, combined with the lack of an available vaccine, means that the majority of carriers are unaware of their positive status. Thus, clinical intervention takes place upon the presentation of symptoms when liver damage is already extensive and when the virus is well established. Current therapy comprises a combination of pegylated alpha interferon (IFN-α) with ribavirin (Rib), which is effective in only 50% of cases and is both expensive and poorly tolerated by patients. This relatively low success rate is due to the highly prevalent, IFN-resistant genotype 1 viruses; other genotypes generally respond well to treatment (27). As IFN-Rib acts primarily via stimulation of the immune system, improving current therapy relies on the development of new, virus-specific drugs. A small number of polymerase and protease inhibitors are at late stages of development, but progress has been hampered by the inability until recently to culture HCV in vitro (21, 40, 45). The highly variable nature of HCV, however, means that new drugs will most likely have to be used in combination, making expansion of available drug targets and the development of new inhibitors a major research focus.HCV is the prototype member of the Hepacivirus genus within the Flaviviridae (3). It is enveloped, and its genome is a 9.6-kb positive-sense RNA. This is translated in a cap-independent fashion from an internal ribosome entry site present within the 5′ untranslated region, yielding a 3,000-amino-acid polyprotein, which is cleaved by both cellular and viral proteases to generate 10 mature virus gene products: the structural proteins core and envelope E1 and E2, the p7 ion channel, and the nonstructural proteins NS2, NS3, NS4A, NS4B, NS5A, and NS5B which replicate the viral genome and regulate host cell metabolism (reviewed in reference 23).The p7 ion channel of HCV is sensitive to several classes of inhibitor compounds in vitro (13, 26, 31) and is necessary for HCV to replicate in chimpanzees (32). Recently, p7 was shown to be critical for the secretion of infectious HCV particles in culture (19, 34), and we along with others have shown that drugs which block its activity significantly reduce virus production (12, 35). p7, therefore, represents an important new target for drug development, and clinical trials combining IFN and Rib with a p7 inhibitor, amantadine, have demonstrated improved response rates in genotype 1-infected individuals (6). Recently, we have shown that the sensitivity of HCV to p7 inhibitors varies according to genotype, implying that p7 sequence determines the binding of inhibitor compounds (12). Little is known about how primary sequence governs p7 channel activity or drug interactions although several mutations have been shown to affect particle secretion in culture (19, 34), including the conserved basic charges on the cytosolic loop, which are known to be required for p7 activity in surrogate cell systems (14).p7 channels are heptameric assemblages (4) with a predicted structure whereby the lumen is formed by the amphipathic amino-terminal trans-membrane helices (13, 25). Carboxy-terminal helices are thought to interact with adjacent p7 protomers, serving to stabilize the channel structure. In addition, the basic loop may form a constriction at one end of the channel, possibly serving to mediate channel gating (13). Accordingly, residues within the loop or the amino-terminal helix would be the most likely to mediate channel opening and/or drug binding.Here, we have investigated determinants of both p7 drug sensitivity and channel activity using a liposome-based fluorescent dye release assay for p7 function (36). Surprisingly, we find that p7 drug sensitivity is not, in fact, determined by either helix nor by the basic loop alone, implying that overall channel structure strongly influences drug binding. Several mutations specifically blocked fluorescent dye release from liposomes without adversely affecting oligomerization or membrane insertion, validating the system as a convenient means of investigating p7 function. Lastly, we identify a region that influences resistance of genotype 1b p7 to amantadine. Developing our understanding of how p7 sequence is linked to drug sensitivity could have important implications for the design of future HCV therapies.     

Long-Term Neurodevelopmental Outcome of Monochorionic and Matched Dichorionic Twins

Background

Monochorionic (MC) twins are at increased risk for perinatal mortality and serious morbidity due to the presence of placental vascular anastomoses. Cerebral injury can be secondary to haemodynamic and hematological disorders during pregnancy (especially twin-to-twin transfusion syndrome (TTTS) or intrauterine co-twin death) or from postnatal injury associated with prematurity and low birth weight, common complications in twin pregnancies. We investigated neurodevelopmental outcome in MC and dichorionic (DC) twins at the age of two years.

Methods

This was a prospective cohort study. Cerebral palsy (CP) was studied in 182 MC infants and 189 DC infants matched for weight and age at delivery, gender, ethnicity of the mother and study center. After losses to follow-up, 282 of the 366 infants without CP were available to be tested with the Griffiths Mental Developmental Scales at 22 months corrected age, all born between January 2005 and January 2006 in nine perinatal centers in The Netherlands. Due to phenotypic (un)alikeness in mono-or dizygosity, the principal investigator was not blinded to chorionic status; perinatal outcome, with exception of co-twin death, was not known to the examiner.

Findings

Four out of 182 MC infants had CP (2.2%) - two of the four CP-cases were due to complications specific to MC twin pregnancies (TTTS and co-twin death) and the other two cases of CP were the result of cystic PVL after preterm birth - compared to one sibling of a DC twin (0.5%; OR 4.2, 95% CI 0.5–38.2) of unknown origin. Follow-up rate of neurodevelopmental outcome by Griffith''s test was 76%. The majority of 2-year-old twins had normal developmental status. There were no significant differences between MC and DC twins. One MC infant (0.7%) had a developmental delay compared to 6 DC infants (4.2%; OR 0.2, 95% 0.0–1.4). Birth weight discordancy did not influence long-term outcome, though the smaller twin had slightly lower developmental scores than its larger co-twin.

Conclusions

There were no significant differences in occurrence of cerebral palsy as well as neurodevelopmental outcome between MC and DC twins. Outcome of MC twins seems favourable in the absence of TTTS or co-twin death.     

Estimation of oxygen evolution by marine phytoplankton from measurement of the efficiency of Photosystem II electron flow

The relation between photosynthetic oxygen evolution and Photosystem II electron transport was investigated for the marine algae t Phaeodactylum tricornutum, Dunaliella tertiolecta, Tetraselmis sp., t Isochrysis sp. and t Rhodomonas sp.. The rate of Photosystem II electron transport was estimated from the incident photon flux density and the quantum efficiency of Photosystem II electron transport as determined by chlorophyll fluorescence. The relation between the estimated rate of Photosystem II electron transport and the rate of oxygen evolution was investigated by varying the ambient light intensity. At limiting light intensities a linear relation was found in all species. At intensities approaching light saturation, the relation was found to deviate from linearity. The slope of the line in the light-limited range is species dependent and related to differences in absorption cross-section of Photosystem II. The observed non-linearity at high irradiances is not caused by photorespiration but probably by a Mehler-type of oxygen reduction. The relationship could be modelled by including a redox-state dependent oxygen uptake. In the diatom t Phaeodactylum tricornutum, the photochemical efficiency of dark adapted open Photosystem II centers was found to be temperature-dependent with an optimum near 10°C.     

A continuous restriction map from HLA-E to HLA-F. Structural comparison between different HLA-A haplotypes

The class I region of the human major histocompatibility complex contains genes encoding the classical transplantation antigens (HLA-A, B, and C), at least three new class I genes (HLA-E, F, and G) and many class I pseudogenes (including HLA-H). By pulse field gel electrophoresis and using five rare cutter enzymes, we have constructed a precise and continuous map of 1200 kilobases (kb) around HLA-A. The blots were hybridized with HLA-A, E, and F-specific probes and with new probes derived from yeast artificial chromosomes and cosmids of the class I region. We have compared the genomic organization of the same 1200 kb in three homozygous lymphoblastoid cell lines corresponding to three different HLA haplotypes (A3, A24, and A31). The differences in size observed may have been caused by insertions and deletions and may prove valuable in understanding the evolution of the HLA chromosomal region.     

Molecular characterization of glutathione reductase cDNAs from pea (Pisum sativum L.)

A cDNA for pea glutathione reductase has been cloned and sequenced. The derived amino acid sequence of 562 residues shows a high degree of homology to the previously published GR sequences from human erythrocytes and from two prokaryotes: Escherichia coli and Pseudomonas aeruginosa. The pea enzyme differs from other GRs in having an N-terminal leader sequence of about 60-70 residues which may be a chloroplast transit peptide and a 20 amino acid C-terminal extension of unknown function.     

First example of photomagnetic effects in ionic pairs [Ni(bipy)3]2[Mo(CN)8] · 12H2O

Ionic triads formed by [Ni^II(bipy)₃]²⁺ (bipy = 2,2′-bipyridyl) and diamagnetic [M^IV(CN)₈]^4? (M = Mo and W) were prepared and structurally characterized. The two compounds are isostructural and their structure consists of a three-dimensional hydrogen-bonded framework where cation–anion interactions occur through short contacts M–CN?H–C(bipy). Before irradiation, the Mo analogue behaves as paramagnet with small intermolecular interactions between the [Ni^II(bipy)₃]²⁺ cations. Upon irradiation with visible light, it exhibits a reversible photomagnetic effect, which is interpreted in terms of the formation of paramagnetic [Mo^V(CN)₈]^3? and [Ni^II(bipy)₂(bipy^?)]⁺ due to the outer-sphere electron transfer.     

Amplification of Nicotiana sylvestris mitochondrial subgenomes is under nuclear control and is associated with phenotypic changes

We have previously shown the presence in a Nicotiana sylvestris protoplast-derived plant of both a nuclear mutation conferring male sterility (ms4) and a mtDNA reorganisation, named U, characterised by the amplification of substoichiometric mtDNA fragments generated by recombination in the parent T mtDNA. Here we show by physical mapping that the recombining repeats are in direct orientation, thus generating two subgenomes both of which are amplified in the U organisation to the detriment of the parent molecule, and are maintained through sexual reproduction. The nuclear ms4 mutation is likely to have play a role in the shift in mitochondrial molecule equilibrium, as higher levels of recombinant fragments were present in protoplast-derived T calli carrying the ms4 allele than in wild type calli or leaves. The MS4 gene could then lead to conflictual situation. However, subgenomic molecules were counter-selected during the regeneration process, suggesting the existence of different selective pressures in differentiated and non-differentiated cells. The U organisation is associated with higher stem height and late flowering, characters that may not be neutral from a selection point of view. The U equilibrium is an unusual example of sudden mtDNA reorganisation, without obvious differences in genetic information and with only a limited phenotypic impact.     

Lipopolysaccharide (LPS)-binding protein mediates LPS detoxification by chylomicrons

Chylomicrons have been shown to protect against endotoxin-induced lethality. LPS-binding protein (LBP) is involved in the inactivation of bacterial toxin by lipoproteins. The current study examined the interaction among LBP, chylomicrons, and bacterial toxin. LBP was demonstrated to associate with chylomicrons and enhance the amount of LPS binding to chylomicrons in a dose-dependent fashion. In addition, LBP accelerated LPS binding to chylomicrons. This LBP-induced interaction of LPS with chylomicrons prevented endotoxin toxicity, as demonstrated by reduced cytokine secretion by PBMC. When postprandial circulating concentrations of chylomicrons were compared with circulating levels of low density lipoprotein, very low density lipoprotein, and high density lipoprotein, chylomicrons exceeded the other lipoproteins in LPS-inactivating capacity. Furthermore, highly purified lipoteichoic acid, an immunostimulatory component of Gram-positive bacteria, was detoxified by incubation with LBP and chylomicrons. In conclusion, our results indicate that LBP associates with chylomicrons and enables chylomicrons to rapidly bind bacterial toxin, thereby preventing cell activation. Besides a role in the detoxification of bacterial toxin present in the circulation, we believe that LBP-chylomicron complexes may be part of a local defense mechanism of the intestine against translocated bacterial toxin.